Eyeing over 80% sales from US, India, Europe by 2021: Glenmark

As part of its medium term strategy, the company is also looking at increasing presence in complex generics, Glenmark said in a presentation to be made at the J P Morgan Healthcare Conference in the US
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news